Compounds > tanshinone ii a
Page last updated: 2024-09-05

tanshinone ii a and n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine

tanshinone ii a has been researched along with n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine in 2 studies

Compound Research Comparison

Studies
(tanshinone ii a)		Trials
(tanshinone ii a)		Recent Studies (post-2010)
(tanshinone ii a)		Studies
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Trials
(n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)		Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine)
6104179116

Protein Interaction Comparison

ProteinTaxonomytanshinone ii a (IC50)n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50)
Cathepsin BHomo sapiens (human)0.0015
procathepsin L isoform 1 preproproteinHomo sapiens (human)0.0026
Calpain-1 catalytic subunitHomo sapiens (human)0.04
Cathepsin BBos taurus (cattle)0.04

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1

Other Studies

2 other study(ies) available for tanshinone ii a and n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine

ArticleYear
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023